Morning Market Movers
December 11, 2013 at 09:56 AM EST
CytRx (NASDAQ: CYTR ) rose 68.20% to $4.02 on positive Phase 2B data. BG Medicine (NASDAQ: BGMD ) moved up 41.67% to $1.53 after the company confirmed final determination by CMS of 2014 reimbursement for BGM galectin-3 test. LiveDeal (NASDAQ: LIVE ) shares jumped 21.34% to $3.98 after the
